FindTrial
Sign In

Stent versus No stent in liver Transplantation

Does Intraductal Stenting In Duct-To-Duct Biliary Reconstruction Reduce Biliary Complications In Living Donor Liver Transplantation ? A Prospective Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005950
Enrollment
80
Registered
2015-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Role of stenting in bile duct anastomosis in reducing biliary anastomotic complications

Interventions

Intervention1: stent: patients of liver transplantation with stent in biliary anastomosis the stent will be removed after 3 months by endoscopy or it would have spontaneously passed stent position was

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients undergoing living donor liver transplantation

Exclusion criteria

Exclusion criteria: pediatric liver transplantation/left lobe graft incompatible blood group transplantation 3 or more bile ducts for anastomosis

Design outcomes

Primary

MeasureTime frame
Bile leak from anastomosisTimepoint: 3 months—

Secondary

MeasureTime frame
Bile duct strictures,Graft function,ICU stay,Interventions in bile leak and biliary stricturesTimepoint: 3 months to 1 year—

Countries

India

Contacts

Public ContactDr Santosh Kumar K Y

Sudhamayi Hospitals and Clinic Amrita Institute of Medical Sciences

santu2293@gmail.com956788481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026